Literature DB >> 2406807

Scleroderma overlap syndromes.

R M Bennett1.   

Abstract

Overlap features with diffuse scleroderma are rare. More commonly, other connective tissue diseases have features usually seen in the systemic involvement of scleroderma. The limited form of scleroderma (CREST) has interesting associations with primary biliary cirrhosis, whereas mixed connective tissue disease evolves toward a scleroderma-like picture with advancing years.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406807

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  13 in total

Review 1.  Autoantibodies and overlap syndromes in autoimmune rheumatic disease.

Authors:  E C Jury; D D'Cruz; W J Morrow
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

Review 2.  B-cell epitopes of scleroderma-specific autoantigens.

Authors:  R Verheijen
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

3.  Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.

Authors:  Hadi Poormoghim; Elham Andalib; Arash Jalali; Afshin Ghaderi; Ali Ghorbannia; Nazanin Mojtabavi
Journal:  Rheumatol Int       Date:  2016-04-09       Impact factor: 2.631

4.  Necrotizing fasciitis in a patient with overlap syndrome of systemic sclerosis and systemic lupus erythematosus.

Authors:  Jong-Hwan Chong; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2009-11-05       Impact factor: 2.631

5.  Follow-up of 151 patients with high-titer U1RNP antibodies.

Authors:  P B Frandsen; N J Kriegbaum; S Ullman; M Høier-Madsen; A Wiik; P Halberg
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

6.  [The German Network for Systemic Scleroderma].

Authors:  P Moinzadeh; A Fehr; B Damm; T Krieg; N Hunzelmann
Journal:  Hautarzt       Date:  2007-10       Impact factor: 0.751

7.  Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.

Authors:  Rudolf Mierau; Pia Moinzadeh; Gabriela Riemekasten; Inga Melchers; Michael Meurer; Frank Reichenberger; Michael Buslau; Margitta Worm; Norbert Blank; Rüdiger Hein; Ulf Müller-Ladner; Annegret Kuhn; Cord Sunderkötter; Aaron Juche; Christiane Pfeiffer; Christoph Fiehn; Michael Sticherling; Percy Lehmann; Rudolf Stadler; Eckhard Schulze-Lohoff; Cornelia Seitz; Ivan Foeldvari; Thomas Krieg; Ekkehard Genth; Nicolas Hunzelmann
Journal:  Arthritis Res Ther       Date:  2011-10-21       Impact factor: 5.156

8.  High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy.

Authors:  Nicolas Hunzelmann; Pia Moinzadeh; Ekkehard Genth; Thomas Krieg; Walter Lehmacher; Inga Melchers; Michael Meurer; Ulf Müller-Ladner; Thorsten M Olski; Christiane Pfeiffer; Gabriela Riemekasten; Eckhard Schulze-Lohoff; Cord Sunderkoetter; Manfred Weber
Journal:  Arthritis Res Ther       Date:  2009-03-04       Impact factor: 5.156

9.  Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.

Authors:  Katharina Hanke; Claudia S Brückner; Cornelia Dähnrich; Dörte Huscher; Lars Komorowski; Wolfgang Meyer; Anthonia Janssen; Marina Backhaus; Mike Becker; Angela Kill; Karl Egerer; Gerd R Burmester; Falk Hiepe; Wolfgang Schlumberger; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2009-02-16       Impact factor: 5.156

10.  Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort.

Authors:  Katharina Hanke; Cornelia Dähnrich; Claudia S Brückner; Dörte Huscher; Mike Becker; Anthonina Jansen; Wolfgang Meyer; Karl Egerer; Falk Hiepe; Gerd R Burmester; Wolfgang Schlumberger; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2009-02-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.